3D Medicines (HKG:1244) said it has received full payment of HK$8 million awarded by an arbitrator in its dispute with Sellas Life Sciences Group, according to a Tuesday Hong Kong bourse filing.
The sole arbitrator had dismissed all claims by Sellas and ordered it to cover 3D Medicines' arbitration costs.
The company said the award has now been fully settled and will not affect the validity or subsequent performance of the license agreement.